RADX

Profile

Full Name

Radiopharm Theranostics Limited

Ticker Symbol

RADX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

December 5, 2024

Indexes

Not included

Website

http://www.radiopharmtheranostics.com

Employees

-

Key Details

Price

$4.19(-2.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$196.20K(-0.25% YoY)

Annual EPS

-$24.41(-13.10% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.19
RADX price is $4.19

30-Day Relative Volume

1.00
RADX 30-day relative volume is 1.00

Price Performance

Price Today change

-2%
RADX price is down -2% today

Price YTD change

-6.76%
RADX price is down -6.76% since January 1st

Price 1-year change

-
RADX price 1-year change is unknown

Price 3-year change

-
RADX price 3-year change is unknown

Price Range

Price All-time high

$50.82
RADX price is currently -91.76% below its historical high of $50.82

Price 3-year low

$3.50
RADX price is currently +19.76% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$32.57M
RADX market capitalization is $32.57 million

Market cap 3-year change

-
RADX market capitalization 3-year change is unknown

Market cap All-time high

$136.90M
RADX market capitalization is currently -76.21% below its historical high of $136.90 million

Market cap sector rank

32.48%
RADX market capitalization is higher than 32.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+424.32%
RADX shares outstanding is up +424.32% year-on-year

Shares Outstanding 3-Year Change

+734.84%
RADX shares outstanding is up +734.84% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.38
RADX beta is 0.38

200-day SMA

$5.38
RADX price is currently -22.15% below its 200-day simple moving average

50-day SMA

$5.13
RADX price is currently -18.47% below its 50-day simple moving average

RSI

40.73
RADX 14-day relative strength index is 40.73

Volume

1.00
RADX 30-day relative volume is 1.00

ATR

$0.77
RADX average true range is $0.77

10-day Historical Volatility

113.37%
RADX 10-day historical volatility is 113.37%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$196.20K
RADX annual revenue is $196.20 thousand

Revenue Analysts estimate

$883.00K
RADX annual revenue is currently -77.78% lower than the consensus analysts' forecast

Revenue 1-year change

-0.25%
RADX annual revenue is down -0.25% year-on-year

Revenue Sector rank

7.26%
RADX annual revenue is higher than 7.26% of companies in Healthcare sector

EPS

EPS

-$24.41
RADX annual earnings per share is -$24.41

EPS Analysts estimate

-$0.02
RADX annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

EPS 1-year change

-13.1%
RADX annual earnings per share is down -13.1% year-on-year

EPS Sector rank

6.05%
RADX annual earnings per share is higher than 6.05% of companies in Healthcare sector

Profit

Gross profit

$196.20K
RADX annual gross profit is $196.20 thousand

Gross margin

-
RADX annual gross profit margin value is unknown

Operating profit

-$24.01M
RADX annual operating income is -$24.01 million

Operating margin

-12.24K%
RADX annual operating profit margin is -12.24 thousand%

Net income

-$31.43M
RADX annual net profit is -$31.43 million

Net margin

-16.02K%
RADX annual net profit margin is -16.02 thousand%

Expenses

Total expenses

$24.20M
RADX annual total expenses is $24.20 million

Operating expenses

$24.20M
RADX annual total operating expenses is $24.20 million

Cost of goods sold

-
RADX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$9.98M
RADX annual SGA is $9.98 million

Depreciation and amortization

-
RADX annual depreciation & amortization value is unknown

Interest expense

$421.50K
RADX annual interest expense is $421.50 thousand

Income tax

$63.20K
RADX annual income tax is $63.20 thousand

EBIT & EBITDA

EBIT

-$30.95M
RADX annual earnings before interest & taxes is -$30.95 million

EBITDA

-$28.90M
RADX annual EBITDA is -$28.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$48.15M
RADX annual total assets is $48.15 million

Non current assets

$32.88M
RADX annual long term assets is $32.88 million

Current assets

$15.27M
RADX annual total current assets is $15.27 million

Cash and cash equivalents

$12.42M
RADX annual cash & cash equivalents is $12.42 million

Accounts receivable

$536.70K
RADX annual accounts receivable is $536.70 thousand

Inventory

-
RADX annual inventory value is unknown

Liabilities

Total liabilities

$29.87M
RADX annual total liabilities is $29.87 million

Long term liabilities

$18.12M
RADX annual total long term liabilities is $18.12 million

Current liabilities

$11.75M
RADX annual total current liabilities is $11.75 million

Accounts payable

$4.30M
RADX annual accounts payable is $4.30 million

Debt

Total debt

$0.00
RADX annual total debt is $0.00

Total debt 1-year change

0%
RADX {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
RADX annual long term debt value is unknown

Short term debt

-
RADX annual short term debt value is unknown

Equity & Capital

Shareholders equity

$18.80M
RADX annual stockholders equity is $18.80 million

Book value

$18.80M
RADX annual book value is $18.80 million

Retained earnings

-$74.42M
RADX annual retained earnings is -$74.42 million

Working capital

$3.52M
RADX annual working capital is $3.52 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
RADX annual cash flow from operations value is unknown

Cash from operations 1-year change

-
RADX annual cash flow from operations 1-year change is unknown

Cash from investing

-
RADX annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
RADX annual cash flow from investing activities 1-year change is unknown

Cash from financing

$19.59M
RADX annual cash flow from financing activities is $19.59 million

Cash from financing 1-year change

+215.82%
RADX annual cash flow from financing activities is up +215.82% year-on-year

CAPEX

CAPEX

-
RADX annual capital expenditures value is unknown

CAPEX 1-year change

-
RADX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-
RADX annual free cash flow value is unknown

Free cash flow 1-year change

-
RADX annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RADX annual gross profit margin value is unknown

Operating margin

-12.24K%
RADX annual operating profit margin is -12.24 thousand%

Net margin

-16.02K%
RADX annual net profit margin is -16.02 thousand%

ROA & ROE

ROA

-64.31%
RADX annual return on assets is -64.31%

ROE

-129.75%
RADX annual return on equity is -129.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RADX price to earnings ratio value is unknown

PE ratio Sector rank

-
RADX price to earnings ratio is unknown

PB Ratio

PB ratio

0.98
RADX price to book ratio is 0.98

PB ratio Sector rank

44.28%
RADX price to book ratio is higher than 44.28% of companies in Healthcare sector

PS Ratio

PS ratio

-
RADX price to sales ratio value is unknown

PS ratio Sector rank

-
RADX price to sales ratio is unknown

Enterprise value

Enterprise value

$9.91M
RADX enterprise value is $9.91 million

Enterprise value Sector rank

24.81%
RADX enterprise value is higher than 24.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
RADX EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
RADX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.30
RADX annual current ratio is 1.30

Quick ratio

-
RADX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
RADX annual debt to equity ratio is 0.00

Interest coverage ratio

-73.43
RADX annual interest coverage ratio is -73.43

Risk & Stability

Piotroski F-Score

-
RADX piotroski f-score value is unknown

Altman Z-Score

-3.54
RADX altman z-score is -3.54

Analyst ratings

Recent major analysts updates

Mar 12, 25 B. Riley Securities
Buy

Institutional Ownership

Similar stocks

NRXP logo
NRx Pharmaceuticals (NRXP)
ME logo
23andMe Holding Co (ME)
RNXT logo
RenovoRx (RNXT)
SHLT logo
SHL Telemedicine (SHLT)
RBOT logo
Vicarious Surgical (RBOT)
PIII logo
P3 Health Partners (PIII)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
ATRA logo
Atara Biotherapeutics (ATRA)
RVPH logo
Reviva Pharmaceuticals Holdings (RVPH)
  • What is the ticker symbol for Radiopharm Theranostics Limited?
  • Does Radiopharm Theranostics Limited pay dividends?
  • What sector is Radiopharm Theranostics Limited in?
  • What industry is Radiopharm Theranostics Limited in?
  • What country is Radiopharm Theranostics Limited based in?
  • When did Radiopharm Theranostics Limited go public?
  • Is Radiopharm Theranostics Limited in the S&P 500?
  • Is Radiopharm Theranostics Limited in the NASDAQ 100?
  • Is Radiopharm Theranostics Limited in the Dow Jones?
  • When was Radiopharm Theranostics Limited's last earnings report?
  • When does Radiopharm Theranostics Limited report earnings?

What is the ticker symbol for Radiopharm Theranostics Limited?

The ticker symbol for Radiopharm Theranostics Limited is NASDAQ:RADX

Does Radiopharm Theranostics Limited pay dividends?

No, Radiopharm Theranostics Limited does not pay dividends

What sector is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Healthcare sector

What industry is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Biotechnology industry

What country is Radiopharm Theranostics Limited based in?

Radiopharm Theranostics Limited is headquartered in Australia

When did Radiopharm Theranostics Limited go public?

Radiopharm Theranostics Limited's initial public offering (IPO) was on December 5, 2024

Is Radiopharm Theranostics Limited in the S&P 500?

No, Radiopharm Theranostics Limited is not included in the S&P 500 index

Is Radiopharm Theranostics Limited in the NASDAQ 100?

No, Radiopharm Theranostics Limited is not included in the NASDAQ 100 index

Is Radiopharm Theranostics Limited in the Dow Jones?

No, Radiopharm Theranostics Limited is not included in the Dow Jones index

When was Radiopharm Theranostics Limited's last earnings report?

Radiopharm Theranostics Limited's most recent earnings report was on Jan 30, 2025

When does Radiopharm Theranostics Limited report earnings?

The next expected earnings date for Radiopharm Theranostics Limited is May 30, 2025
On this page